Ann Marie O'Neill/Linkedin
Aug 22, 2025, 14:36
Join the Thrombosis UK Survey on Severe Thrombophilia: Improve Diagnosis and Treatment Worldwide
Ann Marie O’Neill, a member of The World Thrombosis Day Steering Committee, shared a post on Linkedin:
“Help shape the future of thrombophilia care
Patients living with severe thrombophilia are invited to participate in an important research opportunity.
This research initiative aims to gather critical insights directly from patients to inform global efforts in improving diagnosis, treatment protocols and overall patient outcomes.
The survey is for patients living with severe thrombophilia, including:
- Antithrombin Deficiency
- Protein C Deficiency
- Protein S Deficiency
- Homozygous Factor V Leiden
- Combinations such as Factor V Leiden and Prothrombin 20210.”

Patients living with severe thrombophilia are invited to participate in an important research opportunity developed by Thrombosis UK.
For the survey, check here.
Find similar posts on Hemostasis Today.
-
Aug 31, 2026, 15:44Andrea Boccatonda: Special Issue on Pulmonary Embolism and Venous Thromboembolism
-
Aug 31, 2026, 15:41Adrien Jossart: Acute Thrombotic Storm Following Single Heparin Bolus
-
Aug 31, 2026, 15:36Bernhard Gerber: Myocardial Platelet Activation Linked to Microvascular Obstruction After STEMI
-
Aug 31, 2026, 15:34Higher Fibrinogen γ′ Linked to Increased Risk of Recurrent Arterial Thrombosis – Journal of Thrombosis and Haemostasis
-
Aug 31, 2026, 15:21Ney Carter Borges: Anticoagulation Versus Antiplatelet Therapy After TAVI ESC 26
-
Aug 31, 2026, 15:13Nahid A. Qushmaq: MicroRNAs as Prognostic Biomarkers in Septic Patients
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?